Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report

Large cell neuroendocrine carcinoma (LCNEC) of the lung with epidermal growth factor receptor (EGFR) mutation is rare, and few cases have been treated with EGFR tyrosine kinase inhibitors (TKIs). We report the treatment of combined LCNEC with adenocarcinoma harboring an EGFR mutation with EGFR-TKIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Muto, Satoshi, Ozaki, Yuki, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Shio, Yutaka, Hashimoto, Yuko, Suzuki, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772843/
https://www.ncbi.nlm.nih.gov/pubmed/33442360
http://dx.doi.org/10.1159/000511112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772843/
https://www.ncbi.nlm.nih.gov/pubmed/33442360
http://dx.doi.org/10.1159/000511112

Ejemplares similares